A single intravitreal injection of UBX1325 (foselutoclax) was shown to be safe in patients with diabetic macular edema. The ...

Akeso Pharmaceuticals and Summit Therapeutics have reported that their PD-1/VEGF bispecific antibody has met the primary ...

BPC-157, a pentadecapeptide derived from an endogenously occurring protein sequence in gastric juice, has garnered attention ...

New research shows caffeine supports blood vessel repair in lupus patients by boosting endothelial progenitor cell survival ...

This Research Topic is part of the Insights in Vascular Physiology series:Insights in Vascular Physiology: 2024We are now in ...

Explore the differences between turmeric and curcumin, their unique health benefits, and how to determine which supplement ...

Yesafili, a vascular endothelial growth factor inhibitor, is used to treat several different types of ophthalmology ...

Vascular endothelial growth factor inhibitors (VEGFIs) have transformed treatment paradigms for several malignancies. By ...

Researchers have developed a cutting-edge chip technology capable of precisely mimicking the interactions between cancer cells and blood vessels, akin to the human body environment. This innovation is ...

Yesafili, a vascular endothelial growth factor (VEGF) inhibitor, is a biosimilar to the widely used ophthalmology drug Eylea ...

Biocon Biologics Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved JOBEVNE™ (bevacizumab-nwgd), a ...

A recent study has uncovered a potential breakthrough in treating osteonecrosis of the femoral head (ONFH), a debilitating ...